CASP1 and plasma cell myeloma: Parallel previous findings in colorectal cancer mice models [29–32], multiple myeloma patients [33], and lung cancer patients [34] suggesting a protective role of the NLRP3 inflammasome against cancer development as they showed that NLRP3 and/or CASP1 levels were significantly downregulated in these different cancers.